Pharmaceutical companies are preparing to ramp up the mass production of a cheap generic drug that UK scientists say is the first treatment to significantly cut mortality in severe coronavirus patients.
India-based Cipla, one of the world’s largest generics drug manufacturers, said it would “immediately” resume production of the tablet form of the drug dexamethasone after a trial by Oxford university found it reduced the death rate for seriously ill Covid-19 patients on ventilators by one-third.
“We make eye drops of dexamethasone and we will start tablets for India any day now,” its chairman Yusuf Hamied told the Financial Times.
您已閱讀16%（636字），剩余84%（3430字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。